Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 60-63

  Li, Lian ^a   Mei, Tong Hua ^a   Zhou, Xiang Dong ^a   Zhang, Xin Gao ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZIGONG FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Immunohistochemistry; MMP 26 protein; Non small cell lung cancer

Indexed keywords

MATRIX METALLOPROTEINASE 26;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED;

EID: 67651251437     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Weng MX, Wu CH, Yang XP. Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer [J]. 2008, 27(2):191-195.[in Chinese]
2. Lu ZQ, Wang YM, Cao YY, et al. Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma [J]. Ai Zheng, 2007, 26(5):463-468. [in Chinese]
3. de Coignac AB, Elson G, Delneste Y, et al. Cloning of MMP-26. A novel matrilysin-like proteinase[J]. Eur J Biochem, 2000, 267(11): 3323-3329.
4. Marchenko GN, Ratnikov BI, Rozanov DV, et al. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin[J]. Biochem J, 2001, 356 (Pt3):705-718.
5. Ripley D, Tunuguntla R, Susi L, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma[J]. Int J Gynecol Cancer, 2006, 16(5):1794-1800.
6. Yamamoto H, Vinitketkumnuen A, Adachi Y, et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma[J]. Carcinogenesis, 2004, 25(12):2353-2360.
7. Isaka K, Nishi H, Nakai H, et al. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma[J]. Cancer, 2003, 97(1):79-89.
8. Zhao YG, Xiao AZ, Newcomer RG, et al. Activation of pro-gelatinase B by endometase/MMP-26 promotes invasion of human prostate cancer cells[J]. J Biol Chem, 2003, 278(17):15056-15064.
9. Bister V, Skoog T, Virolainen S, et al. Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma[J]. Mod Pathol, 2007, 20(11):1128-1140.
10. Chen XL, Zhang WG, Chen XY, et al. Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer [J]. Ai Zheng, 2006, 25(9):1134-1137. [in Chinese]
11. Scharl A, Vierbuchen M, Conradt B, et al. Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody[J]. Arch Gynecol Obstet, 1990, 247(2):63-71
12. Uría J A, López-Otín C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity[J]. Cancer Res, 2000,60(17):4745-4751.
13. Park H, Turk BE, Gerbera FE, et al. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26[J]. J Boil Chem 2002,277(38):35168-35175.
14. Savinov AY, Remacle AG, Golubkov VS, et al. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients[J]. Cancer Res, 2006, 66(5):2716-2724.
15. Lee S, Desai KK, Iczkowski KA, et al. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor[J]. Cell Res, 2006,16(9):750-758.
16. Wu XQ, Li YX, Fu YY, et al. Effect of matrix metalloproteinase-26 on cell invasiveness in human choriocarcinomal cell line JEG-3[J]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Jin Zhan, 2006,33(6):524-530.[in Chinese]